E-Prescribing for Optometry That Lives Inside the Chart

The prescribing flow follows the clinical flow. By the time an optometrist reaches the plan portion of the encounter, the chief complaint, findings, assessment, and ICD-10 codes are already in the chart. Prescribing is the next click, not a context switch into a separate application. The OD opens the medication picker, searches the formulary, and selects the drug, strength, dose, route, quantity, and number of refills. For ophthalmic drops, sig templates fill in common instructions such as one drop in the affected eye a set number of times per day.

Before the prescription can be signed, Jelo screens it against the patient's recorded allergies and active medication list. If the patient has a sulfa allergy and the OD reaches for a sulfonamide, or if a systemic medication on the record creates a meaningful interaction with an oral agent the doctor is about to prescribe, an alert surfaces in line. The doctor reviews, acknowledges, and either overrides with a documented reason or changes the order. The clinical judgment stays with the OD; the software simply makes the preventable conflict impossible to miss.

The OD then selects the pharmacy. Jelo searches the national pharmacy network by name or location, and the patient's preferred pharmacy is remembered for next time. The doctor signs, and the prescription transmits electronically. The patient can pick up without a paper script, and your front desk does not field a pharmacy callback. The full prescription, including the sig, quantity, refills, and the pharmacy it went to, is written into the patient record next to the exam that produced it. This is the same record your team uses for billing and coding, so a glaucoma follow-up, its prescription, and its claim all share one timeline.

The practical payoff shows up at the front desk as much as in the lane. With paper and fax prescribing, a meaningful share of a staff member's day is consumed by pharmacy phone tag: confirming a drug was received, re-faxing an illegible script, relaying a refill the doctor already approved, or fielding a patient who arrived at the counter only to find nothing was waiting. Electronic transmission collapses that loop. The prescription is at the pharmacy the moment the OD signs, the status is visible in the chart, and the patient simply picks up. The staff time that used to disappear into the phone is redirected to scheduling, optical sales, and recall, which are the activities that actually grow an independent practice.

For doctors, the gain is cognitive load. Prescribing on paper forces the OD to hold drug names, strengths, and standard sigs in memory, then write them legibly under time pressure. A formulary-backed picker with sig templates removes that memory tax and the handwriting risk that rides along with it. The doctor spends attention on the clinical decision, which medication is right for this patient with this history, rather than on the mechanics of getting a legible, complete order onto a pad and into a pharmacy.

Yes, and the reasons are mechanical rather than aspirational. Paper prescribing introduces error at three distinct points: the doctor's handwriting, the pharmacist's interpretation of that handwriting, and the manual lookup of allergies and interactions that a busy clinician may skip. Electronic prescribing removes the first two entirely by transmitting structured data, and it automates the third so the check happens on every order rather than only when someone remembers to run it. That is why electronic prescribing is treated as a patient-safety improvement by payers and regulators, not merely a convenience.

In optometry the most common preventable errors are dose and frequency mistakes on drops, allergy oversights, and duplicate or conflicting therapy. A patient on a topical beta-blocker for glaucoma who is also on a systemic beta-blocker, a patient with a documented penicillin or sulfa allergy receiving a conflicting antibiotic, or a patient handed a steroid drop without the follow-up schedule that pressure monitoring requires, are all cases where an in-line check changes the outcome. Jelo runs these screens before the prescription can be signed and keeps the doctor in control of the decision, so the safety net never becomes a substitute for clinical judgment.

The error reduction also compounds over time because the medication list stays accurate. Every prescription written in Jelo updates the patient's active medications, so the next interaction check runs against current reality rather than a stale list someone forgot to update. Over years of glaucoma management or recurrent dry-eye treatment, that maintained list is what makes each subsequent check trustworthy.

Refills are where chronic eye care lives, and they are exactly where paper workflows break down. A glaucoma patient may stay on the same drop for years, generating refill request after refill request, each one historically arriving as a fax or a phone call that pulls a staff member away from the front desk and then waits for the doctor to be free. In Jelo, the pharmacy's electronic refill request lands directly in the chart. The OD opens it and sees the original prescription, the diagnosis, the most recent exam, and the patient's current medication list in one view, then approves, modifies, or denies and re-transmits without leaving the record.

Keeping refills in the chart also protects the clinical cadence that chronic care depends on. If a glaucoma patient is overdue for a pressure check, the refill request is the moment to surface that, and because the request sits next to the exam history, the doctor can see at a glance whether it is appropriate to refill or whether the patient needs to be brought back first. Every refill action is written to the same audit trail as the original prescription, so the medication history for any patient is complete and reconstructable, which matters both for continuity of care and for documentation.

Yes, within the limits of state scope of practice and DEA registration. Therapeutic optometrists who hold a valid DEA number can prescribe certain controlled substances, most commonly oral analgesics for acute ocular pain, in many states. What an individual OD may prescribe is set by two things: the prescribing authority granted by the doctor's state board, and the schedules covered by the doctor's DEA registration. The American Optometric Association tracks the steady expansion of therapeutic prescribing authority across the states.

Electronic prescribing of controlled substances, or EPCS, carries requirements beyond ordinary e-prescribing. The DEA Diversion Control Division mandates identity proofing of the prescriber, two-factor authentication at the moment of signing, and a tamper-evident audit trail. Jelo supports these controls: the prescriber is identity-proofed, signing a controlled-substance prescription requires a second authentication factor, and every EPCS action is written to an immutable log. The doctor still confirms that the medication is within the schedules their DEA registration permits before the prescription transmits.

Because scope of practice differs by state, Jelo treats the OD's prescribing authority as a configuration of the account rather than a fixed assumption. If your state recently expanded therapeutic privileges, your prescribing setup reflects it. If you do not prescribe controlled substances at all, the EPCS path stays out of the way and you use ordinary e-prescribing for ophthalmic drops and oral antibiotics.

It is worth being precise about the two layers of authority involved, because they are frequently conflated. State law defines what an optometrist may prescribe at all, including whether oral medications and controlled substances are within scope and which schedules are permitted. A separate DEA registration is what authorizes any prescriber, OD or otherwise, to handle controlled substances within those schedules, and EPCS is the electronic mechanism the DEA requires for transmitting them. An optometrist needs the state grant, the DEA registration, and an EPCS-capable system aligned before a single controlled-substance prescription can go out electronically. Jelo sits in that third layer and is built to meet the DEA's technical requirements, while the first two layers remain the doctor's and the state's responsibility.

The bulk of optometric prescribing is topical. For glaucoma, ODs prescribe prostaglandin analogs, beta-blockers, alpha agonists, carbonic anhydrase inhibitors, and the fixed-combination drops that consolidate them, then manage refills over years of follow-up. For ocular infection, optometrists reach for topical fluoroquinolones, aminoglycosides, and macrolides, and for herpetic disease, topical and oral antivirals. Inflammation and dry-eye care bring topical steroids, immunomodulators, and lubricant and secretagogue therapies, while ocular allergy is handled with antihistamine and mast-cell-stabilizing drops. Each of these flows through the same Jelo prescribing path, with the formulary pre-loaded so the doctor is not typing drug names from memory.

Safety is where electronic prescribing earns its place in the workflow. The Centers for Medicare & Medicaid Services e-prescribing program and a body of peer-reviewed work indexed on PubMed document that electronic prescribing reduces preventable medication errors relative to paper and fax. The mechanism is straightforward: handwriting is removed, dose and quantity are structured, and allergy and interaction checks run automatically at the point of care rather than depending on a busy clinician remembering every contraindication.

For optometry specifically, the interaction surface matters because patients are frequently older and on systemic medications. A patient on oral beta-blockers for hypertension who is about to be started on a topical beta-blocker for glaucoma, or a patient whose recorded allergy conflicts with a proposed antibiotic, is exactly the case an automated check is built to catch. Jelo surfaces the alert, the OD decides, and the decision is documented in the record.

Therapeutic prescribing authority for optometrists has expanded substantially over the past few decades, and it continues to differ from state to state. Every state now allows some level of therapeutic prescribing, but the specifics, oral agents, the range of permitted ophthalmic medications, and whether any controlled substances are included, vary by jurisdiction and continue to evolve through legislation. A platform that hard-codes one set of assumptions about what an OD can prescribe will be wrong for a meaningful number of doctors. Jelo treats prescribing privileges as account configuration, so a practice in a state with broad therapeutic authority and a practice in a more restrictive state both get a prescribing experience that matches their actual scope rather than a generic default.

The reason e-prescribing belongs inside the EHR rather than in a bolt-on tool is data gravity. When a prescription is written from the same chart that holds the exam, the medication automatically attaches to the encounter, the diagnosis that justified it, and the patient's longitudinal medication list. A year later, when the patient returns for a glaucoma check, the OD opens one record and sees the full history: the prior pressures, the current drops, the refill pattern, and the next claim to file. There is no reconciliation step because there were never two systems to reconcile.

That same single record powers the rest of the practice. The encounter that generated a prescription is the encounter your team codes and bills through optometry billing software, and the ICD-10 and CPT codes tie the clinical and the financial sides of the visit together. Scheduling the follow-up, sending the recall, and verifying benefits all read from the same patient profile. This is the core idea behind optical practice management done as one platform rather than a stack of integrations.

Because Jelo is cloud-based optometry software, the doctor can prescribe from any exam lane or location, and multi-location groups share one formulary and one patient record across sites. If you are comparing platforms on this capability, our best optometry software roundup walks through how prescribing, charting, and billing should fit together.

The contrast with a bolt-on e-prescribing tool is sharpest exactly here. A standalone prescribing application can transmit a script to a pharmacy perfectly well, but it does not know the patient's diagnosis from this morning's exam, it does not update the medication list the EHR relies on, and it does not connect the prescription to the claim. Every one of those gaps becomes a manual reconciliation task for your staff, and every manual task is a place for the record to drift out of sync. When prescribing is native to the EHR, the drift simply has nowhere to occur because there is only ever one copy of the truth.

That single-record model is also what makes the AI layer useful rather than risky. Jelo's built-in AI agent can draft assessments and suggest ICD-10 codes during the exam precisely because it is reading the same chart the OD is prescribing from, and the doctor approves every code and every prescription before anything is committed. The automation accelerates the parts of the visit that are clerical, while the clinical authority, what to prescribe, whether to refill, when to bring a patient back, stays entirely with the optometrist.